SMi's is pleased to announce its Generics, Supergenerics and Patent Strategies conference that will provide you with an excellent overview of the industry and where it stands, along with case studies from the big players in the market showing how they have handled issues and how they see the industry moving forward. We will also be covering some of the current regulatory issues and evaluating big Pharma perspective of their movements in the generic field.

The pharmaceutical generics industry is a fast moving and is a consistently expanding one. With the much referenced patent cliff rapidly approaching, all businesses are looking to generics for a source of additional revenue.

Benefits of attending include:

Discuss how successful branded generics and supergenerics value for money and how they actually perform in the market

Evaluate the state of the European markets as well at the emerging markets of the MENA regions.

Hear how some large Pharma companies are making moves into generics production in order to compensate for the lack of upcoming blockbuster drugs.

Gain knowledge of current regulatory issues both from industrial representatives and from the regulatory bodies themselves.

Consider the effects of Asian companies entering the European market

Learn about recent patent litigation and the effect it will have on future trials, as well as recent developments in supplementary patent certificates.

For further information visit www.smi-online.co.uk/goto/generic-pharma42.asp or alternatively contact Lola Ameh on tel 44 0207 827 6722 or email on lameh@smi-online.co.uk

The SMi Group is a world leader in business to business information. With nearly two decades in the business, thousands of senior executives from blue chip companies have already benefitted from SMi’s highly targeted conferences, workshops and publications. For more information visit www.smi-online.co.uk

SMi Group Ltd
2nd Floor South, Harling House 47-51 Great Suffolk Street,
London, SE1 0BS

This release was published on openPR.